Financial Performance - Standalone (Amount in ₹ Crores, except per share data)
Quarter Ended September 30, 2026:
- Revenue from operations: ₹441.17
- Other income: ₹2.48
- Total income: ₹443.65
- Total expenses: ₹363.03
- Profit before exceptional item and tax: ₹80.62
- Exceptional items: None (₹0.00)
- Profit before tax: ₹80.62
- Tax expense: ₹20.44 (Current: ₹18.43, Deferred: ₹2.01)
- Net profit after tax: ₹60.18
- Other comprehensive loss: ₹(0.72)
- Total comprehensive income: ₹59.46
- Basic EPS: ₹9.84
- Diluted EPS: ₹9.84
Half Year Ended September 30, 2026:
- Revenue from operations: ₹863.60
- Other income: ₹5.63
- Total income: ₹869.23
- Total expenses: ₹708.26
- Profit before exceptional item and tax: ₹160.97
- Exceptional items: None (₹0.00)
- Profit before tax: ₹160.97
- Tax expense: ₹40.69 (Current: ₹36.81, Deferred: ₹3.88)
- Net profit after tax: ₹120.28
- Other comprehensive loss: ₹(1.02)
- Total comprehensive income: ₹119.26
- Basic EPS: ₹19.67
- Diluted EPS: ₹19.67
Financial Performance - Consolidated
Quarter Ended September 30, 2026:
- Net profit after tax: ₹60.31
- Share of profit from associate: ₹0.13
- Basic EPS: ₹9.86
Half Year Ended September 30, 2026:
- Net profit after tax: ₹120.42
- Share of profit from associate: ₹0.14
- Basic EPS: ₹19.69
Balance Sheet Position (Standalone as at September 30, 2026)
- Total assets: ₹1,245.70 crore
- Non-current assets: ₹772.02 crore
- Current assets: ₹473.68 crore
- Total equity: ₹804.07 crore
- Equity share capital: ₹61.16 crore
- Other equity: ₹742.91 crore
- Total liabilities: ₹441.63 crore
Cash Flow Statement (Standalone H1 FY27)
- Net cash from operating activities: ₹112.73 crore
- Net cash from investing activities: ₹3.30 crore
- Net cash used in financing activities: ₹(116.28) crore
- Net decrease in cash: ₹(0.25) crore
- Cash and cash equivalents at end: ₹1.58 crore
Key Notes and Disclosures
1. The company completed its IPO on December 15, 2025, with offer for sale of 61,74,051 equity shares at issue price of ₹1,008 (employees) and ₹1,062 (others) per share.
2. The financial impact of new Labour Codes notified on November 21, 2025, was recorded as an exceptional item in FY26 amounting to ₹19.10 crore (post-tax ₹14.29 crore), consisting of gratuity (₹13.60 crore) and long-term compensated absences (₹5.50 crore). No impact in current period.
3. The company has one reportable business segment: 'Pharmaceuticals'.
4. As of September 30, 2026, the company held fixed deposits aggregating ₹146.82 crore, against which overdraft facilities of ₹94.28 crore were availed and disclosed under short-term borrowings.
5. The associate company included in consolidated results is La Chandra Pharma Lab Private Limited.
6. The financial results were reviewed by Walker Chandiok & Co LLP, who issued an unmodified review conclusion.
7. Previous period figures have been regrouped/reclassified for comparability.